150 related articles for article (PubMed ID: 38077877)
1. Retracted: Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9818549. PubMed ID: 38077877
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.
Le Y; Kong H; Gao X; Zhu J
Comput Math Methods Med; 2022; 2022():8371885. PubMed ID: 36017155
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Prognostic Significance of ANGPTL4 in Lung Adenocarcinoma: A Meta-Analysis Based on Integrated TCGA and GEO Databases.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9852450. PubMed ID: 37476348
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and Immunological Role of FUN14 Domain Containing 1 in Pan-Cancer: Friend or Foe?
Yuan Q; Sun N; Zheng J; Wang Y; Yan X; Mai W; Liao Y; Chen X
Front Oncol; 2019; 9():1502. PubMed ID: 31998650
[No Abstract] [Full Text] [Related]
5. Retracted: Irisin Attenuates Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in the H9C2 Cellular Model of Septic Cardiomyopathy through Augmenting Fundc1-Dependent Mitophagy.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9790868. PubMed ID: 37868725
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9815950. PubMed ID: 38230074
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2023; 2023():9841321. PubMed ID: 38075334
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
[TBL] [Abstract][Full Text] [Related]
12. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
[TBL] [Abstract][Full Text] [Related]
13. Retracted: DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
International BR
Biomed Res Int; 2024; 2024():9824604. PubMed ID: 38549965
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9808126. PubMed ID: 38550199
[TBL] [Abstract][Full Text] [Related]
17. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
Oncology JO
J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
International BR
Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
